This site is intended for healthcare professionals
  • Home
  • /
  • Journals
  • /
  • Multiple myeloma
  • /
  • The potential of ixazomib, a second-generation pro...
Journal

The potential of ixazomib, a second-generation proteasome inhibitor, in the treatment of multiple myeloma.

Read time: 1 mins
Published:1st Jul 2017
Author: Brayer J, Baz R.
Availability: Free full text
Ref.:Ther Adv Hematol. 2017;8(7):209-220.
DOI:10.1177/2040620717710171
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest